Q Futures

Technology strategies to deliver business value

In 2007 Q Futures signed a deal with AstraZeneca by which Q Futures undertook to identify partners to realise value from a number of patents in the drug discovery, diagnostics and general life science areas. These patents are available for licensing or other exploitation arrangements. The portfolio comprises:

A method for detecting DNA sequences by fluorescence polarisation
A method for preparing FRET protease substrates
A method for screening compounds in a gel format
Microfabricated apparatus for cell electrophysiology
Cell based assay for inhibitors of sterol biosynthesis
Microfabricated device for cell injection
Microfabricated device for cell electroporation
Microfabricated device for electrochemical reactions
Microfabricated device for photochemical reactions
High throughput receptor binding assay using radial partition
Compound collection storage method

If you are interested in any of these technologies, please get in touch with us.